Impact of autologous stem cell transplantation (ASCT) on progression free survival (PFS) in newly diagnosed multiple myeloma patients (NDMM) with high risk cytogenetic abnormalities
Bratislava Medical Journal · 2023
DOI: 10.4149/bll_2024_002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bratislava Medical Journal, 2023. Verfasst von Tomas Guman und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Multiple Myeloma.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Zitieren
APA
Guman, T., & Sykora, J. (2023). Impact of autologous stem cell transplantation (ASCT) on progression free survival (PFS) in newly diagnosed multiple myeloma patients (NDMM) with high risk cytogenetic abnormalities. Bratislava Medical Journal. https://doi.org/10.4149/bll_2024_002
Vancouver
Guman T, Sykora J. Impact of autologous stem cell transplantation (ASCT) on progression free survival (PFS) in newly diagnosed multiple myeloma patients (NDMM) with high risk cytogenetic abnormalities. Bratislava Medical Journal. 2023. doi:10.4149/bll_2024_002
BibTeX
@article{Guman2023,
author = {Guman, Tomas and Sykora, Jan},
title = {Impact of autologous stem cell transplantation (ASCT) on progression free survival (PFS) in newly diagnosed multiple myeloma patients (NDMM) with high risk cytogenetic abnormalities},
journal = {Bratislava Medical Journal},
year = {2023},
doi = {10.4149/bll_2024_002}
}
EUVIMED